<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960412</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00026976</org_study_id>
    <nct_id>NCT02960412</nct_id>
  </id_info>
  <brief_title>Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy</brief_title>
  <official_title>Randomized Controlled Trial Evaluating Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates if administration of IV furosemide leads to expedited confirmation of
      ureteral patency when compared to placebo (IV saline) in routine cystoscopy performed after
      urogynecologic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cystoscopy is performed routinely after urogynecologic surgery to ensure there was no injury
      to the urinary tract (urethra, bladder, or ureters). In order to confirm that no damage
      occurred to the ureters, a jet of urine must be visualized from each ureteral opening.

      The time it takes to confirm this ureteral patency is variable and some sources suggest using
      furosemide to decrease the time it takes to see these jets. This study will evaluate what
      effect, if any, this medicine has on time to confirming ureteral patency.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to ureteral patency</measure>
    <time_frame>intra-operative</time_frame>
    <description>time to confirmation of ureteral patency in seconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse effects from furosemide administration</measure>
    <time_frame>immediately post operative (1-3 days post operatively)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Cystoscopy</condition>
  <arm_group>
    <arm_group_label>furosemide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>furosemide 10mg (1mL) IV push for one dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline 1mL IV push for one dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>furosemide</intervention_name>
    <description>10mg lasix given intraoperatively</description>
    <arm_group_label>furosemide</arm_group_label>
    <other_name>Lasix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Normal saline given intraoperatively as placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing any urogynecologic surgery

          -  No allergy or contraindication to receiving furosemide

          -  Normal Creatinine/glomerular filtration rate

        Exclusion Criteria:

          -  Unable to consent, including if non English speaking

          -  Allergy or contraindication to receiving furosemide

          -  Intraoperative injury to the lower urinary tract
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Simon P Patton, MD</last_name>
    <phone>316-210-4099</phone>
    <email>simonpatton@health.usf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisha Jackson, MD</last_name>
    <phone>813-259-8671</phone>
    <email>ejjackson@health.usf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simon P Patton, MD</last_name>
      <phone>316-210-4099</phone>
      <email>simonpatton@health.usf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Elisha Jackson, MD</last_name>
      <phone>813-259-8671</phone>
      <email>ejjackson@health.usf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Simon P Patton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2016</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Furosemide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

